Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

157 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Olverembatinib After Failure of Tyrosine Kinase Inhibitors, Including Ponatinib or Asciminib: A Phase 1b Randomized Clinical Trial.
Jabbour E, Oehler VG, Koller PB, Jamy O, Lomaia E, Hunter AM, Uspenskaya O, Samarina S, Mukherjee S, Cortes JE, Baer MR, Zherebtsova V, Shuvaev V, Turkina A, Davydkin I, Guo H, Chen Z, Fu T, Jiang L, Wang C, Wang H, Yang D, Zhai Y, Kantarjian H. Jabbour E, et al. Among authors: shuvaev v. JAMA Oncol. 2024 Nov 21:e245157. doi: 10.1001/jamaoncol.2024.5157. Online ahead of print. JAMA Oncol. 2024. PMID: 39570620
Physiologically based modeling of LNP-mediated delivery of mRNA in the vascular system.
Parhiz H, Shuvaev VV, Li Q, Papp TE, Akyianu AA, Shi R, Yadegari A, Shahnawaz H, Semple SC, Mui BL, Weissman D, Muzykantov VR, Glassman PM. Parhiz H, et al. Among authors: shuvaev vv. Mol Ther Nucleic Acids. 2024 Mar 18;35(2):102175. doi: 10.1016/j.omtn.2024.102175. eCollection 2024 Jun 11. Mol Ther Nucleic Acids. 2024. PMID: 38576454 Free PMC article.
Targeting lipid nanoparticles to the blood-brain barrier to ameliorate acute ischemic stroke.
Nong J, Glassman PM, Shuvaev VV, Reyes-Esteves S, Descamps HC, Kiseleva RY, Papp TE, Alameh MG, Tam YK, Mui BL, Omo-Lamai S, Zamora ME, Shuvaeva T, Arguiri E, Gong X, Brysgel TV, Tan AW, Woolfork AG, Weljie A, Thaiss CA, Myerson JW, Weissman D, Kasner SE, Parhiz H, Muzykantov VR, Brenner JS, Marcos-Contreras OA. Nong J, et al. Among authors: shuvaev vv. Mol Ther. 2024 May 1;32(5):1344-1358. doi: 10.1016/j.ymthe.2024.03.004. Epub 2024 Mar 7. Mol Ther. 2024. PMID: 38454606
Targeting lipid nanoparticles to the blood brain barrier to ameliorate acute ischemic stroke.
Nong J, Glassman PM, Reyes-Esteves S, Descamps HC, Shuvaev VV, Kiseleva RY, Papp TE, Alameh MG, Tam YK, Mui BL, Omo-Lamai S, Zamora ME, Shuvaeva T, Arguiri E, Thaiss CA, Myerson JW, Weissman D, Kasner SE, Parhiz H, Muzykantov VR, Brenner JS, Marcos-Contreras OA. Nong J, et al. Among authors: shuvaev vv. bioRxiv [Preprint]. 2023 Jun 13:2023.06.12.544645. doi: 10.1101/2023.06.12.544645. bioRxiv. 2023. Update in: Mol Ther. 2024 May 1;32(5):1344-1358. doi: 10.1016/j.ymthe.2024.03.004. PMID: 37398465 Free PMC article. Updated. Preprint.
Mechanisms by Which Liposomes Improve Inhaled Drug Delivery for Alveolar Diseases.
Ferguson LT, Ma X, Myerson JW, Wu J, Glassman PM, Zamora ME, Hood ED, Zaleski M, Shen M, Essien EO, Shuvaev VV, Brenner JS. Ferguson LT, et al. Among authors: shuvaev vv. Adv Nanobiomed Res. 2023 Mar;3(3):2200106. doi: 10.1002/anbr.202200106. Epub 2023 Jan 27. Adv Nanobiomed Res. 2023. PMID: 37266328 Free PMC article.
Clinical Outcomes in Patients With COVID-19 and Hematologic Disease.
Aleshina OA, Zakurdaeva K, Vasileva AN, Dubov SK, Dubov VS, Vorobyev VI, Butaev LS, Sukhareva AM, Gavrilova LV, Toropova IY, Popova MO, Siniaev AA, Kulagin AD, Kaplanov KD, Petrenko AA, Ochirova OI, Karpova A, Chelysheva EY, Turkina AG, Gurianova MA, Al-Radi LS, Gilyazitdinova EA, Egorova EK, Chabaeva YA, Kulikov SM, Sveshnikova YV, Kunst MA, Shuvaev V, Rakhmani AF, Panteleeva OL, Grishunina ME, Samoylova OS, Vorontsova E, Baryshnikova DV, Parovichnikova EN. Aleshina OA, et al. Among authors: shuvaev v. Clin Lymphoma Myeloma Leuk. 2023 Aug;23(8):589-598. doi: 10.1016/j.clml.2023.04.002. Epub 2023 Apr 14. Clin Lymphoma Myeloma Leuk. 2023. PMID: 37236904 Free PMC article.
Long-term outcomes of third-line therapy with tyrosine kinase inhibitors in chronic phase chronic myeloid leukemia: A real-life experience.
Chitanava T, Matvienko I, Shuvaev V, Voloshin S, Martynkevich I, Vlasova Y, Efremova E, Mileeva E, Pirkhalo A, Makarova T, Vlasik R, Karyagina E, Il Ina N, Medvedeva N, Dorofeeva N, Shneider T, Siordiya N, Kulemina O, Sbityakova E, Lazorko N, Alexeeva J, Motorin D, Morozova E, Lomaia E. Chitanava T, et al. Among authors: shuvaev v. Front Oncol. 2023 Mar 16;13:1138683. doi: 10.3389/fonc.2023.1138683. eCollection 2023. Front Oncol. 2023. PMID: 37007128 Free PMC article.
Breast tumors interfere with endothelial TRAIL at the premetastatic niche to promote cancer cell seeding.
Riera-Domingo C, Leite-Gomes E, Charatsidou I, Zhao P, Carrá G, Cappellesso F, Mourao L, De Schepper M, Liu D, Serneels J, Alameh MG, Shuvaev VV, Geukens T, Isnaldi E, Prenen H, Weissman D, Muzykantov VR, Soenen S, Desmedt C, Scheele CLGJ, Sablina A, Di Matteo M, Martín-Pérez R, Mazzone M. Riera-Domingo C, et al. Among authors: shuvaev vv. Sci Adv. 2023 Mar 22;9(12):eadd5028. doi: 10.1126/sciadv.add5028. Epub 2023 Mar 22. Sci Adv. 2023. PMID: 36947620 Free PMC article.
Dual Affinity to RBCs and Target Cells (DART) Enhances Both Organ- and Cell Type-Targeting of Intravascular Nanocarriers.
Ferguson LT, Hood ED, Shuvaeva T, Shuvaev VV, Basil MC, Wang Z, Nong J, Ma X, Wu J, Myerson JW, Marcos-Contreras OA, Katzen J, Carl JM, Morrisey EE, Cantu E, Villa CH, Mitragotri S, Muzykantov VR, Brenner JS. Ferguson LT, et al. Among authors: shuvaev vv. ACS Nano. 2022 Mar 22;16(3):4666-4683. doi: 10.1021/acsnano.1c11374. Epub 2022 Mar 10. ACS Nano. 2022. PMID: 35266686 Free PMC article.
157 results